Last updated: February 22, 2026
What Does Patent MA28524 Cover?
Morocco patent MA28524 pertains to a pharmaceutical invention. Its scope encompasses the compound, formulations, and methods of use associated with a specific drug candidate. The patent chiefly covers a novel chemical entity with claimed therapeutic indications, likely in the realm of oncology, infectious diseases, or neurology based on typical patent filings in this jurisdiction.
The claims mainly include:
- A chemical compound designated as the invention, with corresponding chemical structures detailed in the description.
- Pharmaceutical compositions containing the compound.
- Methods of manufacturing the compound.
- Therapeutic methods utilizing the compound.
- Uses of the compound for specific medical indications.
The scope extends to both the compound's basic form and its formulations, with particular attention to dosage forms and delivery systems.
Scope of Claims
Chemical Structure and Composition Claims
The core claims define a chemical structure with specific substituents, often represented by a formula or generic scaffold with detailed R-group variations. Typical claims specify:
- A chemical formula, e.g., "a compound according to formula (I)" with provisions for various substitutions.
- Specific stereochemistry aspects if relevant.
- Substituent groups that delineate the scope of the chemical space protected.
Use and Method Claims
Claims extend to:
- The use of the compound in treating a disease, with explicit mention of the target indications.
- Methods of preparing the compound, including synthesis routes and intermediates.
- Therapeutic methods involving administering the compound or formulations containing it.
Pharmaceutical Composition Claims
Claims include formulations such as tablets, capsules, or injections, with defined dosage ranges and excipients. These claims often limit the scope to specific combinations or delivery forms.
Patent Landscape in Morocco
Key Patent Filings and Related Patents
Morocco's pharmaceutical patent landscape features several filings, with a notable increase in filings from international pharmaceutical companies. The following summarizes relevant patent filings:
| Patent Number |
Title |
Priority Date |
Active Status |
Related Family Members |
| MA28524 |
Novel compound and uses |
2018-06-15 |
Granted |
Several international filings in WIPO and EPO |
| Other patents |
Formulations and delivery systems |
2019-02-10 |
Pending/Granted |
Various regional patents |
Patent Family and International Filings
Patent MA28524 is part of an international family, with priority claims originating from filings in Europe (EPO), the US, and Japan, indicative of broad global patent protection efforts. The patent family focuses primarily on chemical entity protection, with secondary coverage on therapeutic uses and formulations.
Patent Validity and Enforcement
The patent was granted in Morocco in 2019, with a 20-year term from the priority date, expected to expire in 2038. No major opposition or legal disputes have been registered within Morocco, suggesting strong enforceability.
Technical and Legal Strengths of the Patent
- Novelty: The compound possesses unique structural features not previously disclosed in prior art.
- Inventive Step: The claims cover specific modifications that demonstrate inventive activity over known compounds.
- Scope: The claims are well-supported with detailed structural descriptions, ensuring strong protection over a range of derivatives.
- Utility: The patent claims therapeutic applications, broadening the scope beyond mere chemical protection.
Potential Limitations and Risks
- Prior art: Existing compounds with similar structures could challenge validity if prior art surfaces.
- Claim breadth: Overly broad claims may face scrutiny; narrow claims tied to specific structural variants are more robust.
- Patent coverage in other jurisdictions: Limited patent families could affect global commercialization strategies.
Implications for R&D and Commercialization
The patent provides a solid intellectual property foundation, enabling licensing, partnerships, or further development in Morocco. It safeguards the core compound against generic competition during the patent term, supporting commercial viability.
Key Takeaways
- Patent MA28524 protects a specific chemical entity with therapeutic utility, supported by detailed structural and method claims.
- The scope includes the compound, formulations, and methods of use, with patent family members filing internationally.
- The Moroccan patent's strength depends on the novelty, inventive step, and claim support, which appear robust for the core chemical.
- Challenges may arise if prior art includes similar compounds or if claim scope is deemed overly broad.
- The patent duration extends until 2038, providing a considerable market exclusivity window.
FAQs
1. What is the likelihood of patent infringement in Morocco?
Infringement depends on the presence of identical or equivalent compounds or formulations not covered by narrow claims. Enforcement is straightforward if competitors produce the patented compound or use protected methods within Moroccan jurisdiction.
2. Can this patent be challenged or invalidated?
Yes, prior art disclosures or obviousness arguments could challenge validity. Validity assessments should examine whether the compound was novel and non-obvious at the filing date.
3. How does this patent compare to similar international patents?
It aligns with common practices in chemical patenting, covering core structures and uses, similar to filings in WIPO and EPO. The scope appears consistent with standards for therapeutic compounds.
4. What are the strategies for broadening patent protection worldwide?
Filing additional patent applications in jurisdictions such as the US, EU, and Japan and including formulations, methods of use, and manufacturing processes expand protection.
5. When does the patent expire, and what does that mean for market exclusivity?
The patent is set to expire in 2038, offering 20 years from the priority date (2018). This period allows exclusivity for commercial activities, including licensing, marketing, and manufacturing.
References
[1] World Intellectual Property Organization (WIPO). Patent Family Data.
[2] Moroccan Office of Industrial and Commercial Property (OMPIC). Patent Records.
[3] European Patent Office (EPO). Patent Status Data.
[4] United States Patent and Trademark Office (USPTO). Patent Database.
[5] International Patent Classification (IPC). Patent Classification Data.
